China's demand for Anti-Obesity Drugshas grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.
Chinese Markets for Anti-Obesity Drugs April 2009 Published by Asia Market Information and Development Co. Asia Market Information and Development Co. 15002 225th Ave NE Woodinville, WA 98072 USA Phone (425) 844-8585 Fax: (425) 844-8515 Email: firstname.lastname@example.org Web Site: www.ChineseMarketReport.com © Copyright 2009 Asia Market Information and Development Co. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or means, electronic, mechanical, photocopying, recording or otherwise, without permission from Asia Market Information and Development Co. CONTENTS TABLE OF CONTENTS I.INTRODUCTION Report Scope and Methodology Executive Summary II.BUSINESS ENVIRONMENT Economic Outlook Key Economic Indicators Industrial Output Population and Labor Foreign Investment Foreign Trade Financial and Tax Regulations Banking System and Regulations Foreign Exchange Taxes, Tariff and Custom Duties III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS Anti-Obesity Drugs Industry Structure Market Size Market Growth Drivers Anti-Obesity Drugs Industry Capacity Major Producer Facility Locations and Output Locations Output © Copyright 2009 AMID Co. i Contents Market Share of Key Producers Labor Cost Potential Entrants Major Distributors Major Foreign Investments Technology Development IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND Overview Demand of Anti-Obesity Drugs by Region Anti-Obesity Drugs Production and Demand Sibutramine Major Manufacturers Supply and Demand Traditional Chinese Medicine Major Manufacturers Supply and Demand Orlistat Major Manufacturers Supply and Demand Rimonabant Major Manufacturers Supply and Demand Metformin Major Manufacturers Supply and Demand Other Anti-Obesity Drugs Anti-Obesity Drugs Imports and Exports Anti-Obesity Drugs Imports Anti-Obesity r Drugs Exports Pricing Trend V. ANTI-OBESITY DRUGS MARKET OUTLOOK Anti-Obesity Drugs Markets Outlook Overview Government Regulation Health Care Insurance Industry Overview Consumer Spending Trends Demographic Trends Health Care Industry Trends Hospitals and Hospital Beds Physicians and Physician Visits © Copyright 2009 AMID Co. ii Contents VI. MARKETING STRATEGIES China Market Entry Overview China’s Distribution System Cough Drugs Distribution Channels Transportation and Freight Infrastructure Communications China’s Market Entry Export to China Indirect export Direct Export License and Contract Manufacture Assembling in China Contract Manufacturing Trade Permit Investment Equity Joint Venture Contractual Joint Venture Wholly Foreign-Owned Enterprise VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY Profiles of Anti-Obesity Drugs Producers and Major Suppliers © Copyright 2009 AMID Co. iii Contents LIST OF TABLES I. INTRODUCTION Economic Outlook Summary II. BUSINESS ENVIRONMENT Key Economic Indicators Industrial Output Population and Labor Force Trends Foreign Investment and Loans Foreign Trade III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS Anti-Obesity Drugs Industry Output Major Producer Facility Location Major Anti-Obesity Drugs Producer Output in 2007 Market Share of Key Producers Major Foreign Investment in China IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND Anti-Obesity Drugs Production and Demand Demand of Anti-Obesity Drugs by Region in 2004 Major Sibutramine Producer Output and Capacity in 2007 Sibutramine Drugs Production and Demand Major Traditional Chinese medicine Producer Output and Capacity in 2007 Traditional Chinese Medicine Production and Demand Major Orlistat Producer Output and Capacity in 2007 Olistat Production and Demand Rimonabant Production and Demand Major Metformin Producer Output and Capacity in 2007 Metformin Production and Demand Other Anti-obesity Drugs Production and Demand China Anti-Obesity Drugs Imports and Exports © Copyright 2009 AMID Co. iv Contents V. ANTI-OBESITY DRUGS MARKET OUTLOOK Anti-Obesity Drugs Industry Output Major Producer Facility Location Major Anti-Obesity Drugs Producer Output in 2007 Market Share of Key Producers in 2007 Major Foreign Investment in China © Copyright 2009 AMID Co. v Contents LIST OF CHARTS I.INTRODUCTION China’s Anti-Obesity Drugs Capacity, Output, Demand II.BUSINESS ENVIRONMENT China’s GDP and Growth Rate Industrial Output by Ownership China’s Imports and Exports III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS Anti-Obesity Drugs Capacity in China All kinds of Anti-Obesity Drugs Market Share Anti-Obesity Drugs Capacity, Output and Demand IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND Total Anti-Obesity Drugs Production and Demand Total Anti-Obesity Drugs Imports and Exports V. ANTI-OBESITY DRUGS MARKET OUTLOOK Anti-Obesity Drugs Demand by Market in 2009 VI. MARKETING STRATEGIES China’s Distribution Channel © Copyright 2009 AMID Co. vi CHAPTER I INTRODUCTION Report Scope and Methodology This report examines China's macroeconomic trends, investment environment, anti-obesity drugs industry structure and capacities, production and demand, end- use market consumption trends, distribution channels and industry participants. Long-term forecasts for major anti-obesity drugs production and demand are included. The report contains over 31 tables and 11 charts. Key anti-obesity drugs producers and major anti-obesity drugs end user are listed and profiled. Most primary and secondary research is done in China in order to access up-to-date market information and industry data. Data was collected from the telephone interview, Chinese government publications, Chinese official website, China’s official statistic organization, Chinese chemical online databases, Chinese anti- obesity drugs industry associations, and anti-obesity drugs industry publications. Interviews are conducted with Chinese anti-obesity drugs experts, university professors, and anti-obesity drugs producers in China. Historical data include 2003 and 2008. Long-term development trends are projected to the years 2014 and 2019. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values © Copyright 2009 AMID Co. Page 1 Chapter I INTRODUCTION are presented in either Yuan (RMB, current price) and/or US dollars. Exchange rate refers to the real- time exchange rate published by China Central Bank. The word "demand" is used interchangeably with "consumption". Totals may not add due to rounding. The following are the common multivariate statistical analysis that used in this report: 1. regression analysis, 2.factor analysis, 3. discriminate analysis, 4. conjoint analysis, 5. correspondent analysis. Executive Summary The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment. Since its Opening-up and Reform, China becomes the 6th economic entity in the world with GNP breaking RMB 20 trillion Yuan. In recent years, under the background of global economy recession, China remains an average growth rate around 9%, remaining one of the countries with the fastest economy growth. China's economy development has its unique characteristics. First of all, under the obvious slowdown of global economy, China realizes the rapid growth of economy by sticking to the policy of expanding domestic demand and firmly implementing proactive fiscal policy and moderate monetary policy. Secondly, economic structure adjustment obtains positive progress. The agriculture structure has been optimized and high quality and special farm products have been increased. High-tech industries such as © Copyright 2009 AMID Co. Page 2 Chapter I INTRODUCTION information and biology industry have developed rapidly. The reconstruction of traditional industries and the capacity of eliminating backward production have obtained comparatively great headway. Infrastructure construction has made remarkable achievement in completing a set of key projects including highway, railway, interstate road, key water control project and rural electricity network reconstruction. Western development is launched smoothly and import ant project s such as Qinghai- Tibet railway and transmission of electricity from the western to the eastern region has started. Thirdly, the quality and efficiency of economic growth have been further improved. Industrial enterprises output value increase constantly. With the great increase in the taxation, national fiscal revenue realized two digital growths. Fourthly, the foreign economic & trades have been further expanded. The total volume of import and export has broken US$2.568 trillion, of which export volume mounts to US$1.432 trillion and import volume mounts to US$1.136 billion, up 26.7% and 22.4% annually respectively in the last 5 years. Finally, the people's living standard is continuously improved. The per capita disposable income of residents in cities and towns actually increases by 14.9%. Social security expenditures have been greatly increased in the finance of central and local governments. The subsistence allowances for laid-off workers and basic pensions for retirees have been basically fully granted on time. The State lifts the level of pension of retirees and employees of public institutions and organs and increases the basic pension of retirees. The burden of farmers has been relieved by eliminating the agriculture tax which exist for Thousands of years, improve the grain price greatly, speeding up the reconstruction of rural electricity network and trimming the price of electricity. The markets of urban and rural areas have developed © Copyright 2009 AMID Co. Page 3 Chapter I INTRODUCTION prosperously, and the living condition and transportation have been further improved. At present, Chinese economic development is at a crossroads, where its operating mechanism, growth style, development strategy, and existing structure all need changing and adjusting, and the backward of the economic structure is more and more remarkable. In order to keep the China’s economic development on speedy, healthy and sustainable track, government i
Pages to are hidden for
"Chinese Markets for Anti-Obesity Drugs"Please download to view full document